Adverum Biotechnologies (ADVM) Stock Chart & Stock Price History $3.49 +0.16 (+4.80%) Closing price 04:00 PM EasternExtended Trading$3.49 0.00 (0.00%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Adverum Biotechnologies Stock Price Performance 5 Day Performance+19.93%1 Month Performance-18.08%3 Month Performance-17.30%6 Month Performance-52.90%Year-To-Date Performance-25.27%1 Year Performance-65.10% Receive ADVM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adverum Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address ADVM Stock Chart for Friday, May, 2, 2025 ADVM Chart by TradingView Adverum Biotechnologies Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$3.33$3.49+4.80%$3.62$3.38756,145 shs$72.91 million05/01/2025$3.26$3.33+2.15%$3.44$3.17555,523 shs$69.57 million04/30/2025$3.23$3.26+0.93%$3.38$3.08418,101 shs$68.11 million04/29/2025$2.88$3.23+12.15%$3.28$2.791.57 million shs$67.48 million04/28/2025$2.91$2.88-1.03%$2.97$2.64779,942 shs$60.17 million04/25/2025$2.97$2.91-2.02%$3.01$2.811.04 million shs$60.79 million04/24/2025$2.85$2.97+4.21%$3.11$2.85639,022 shs$62.05 million04/23/2025$2.96$2.85-3.72%$3.04$2.82352,365 shs$59.54 million04/22/2025$2.73$2.96+8.42%$3.02$2.74594,664 shs$61.84 million04/21/2025$2.93$2.73-6.83%$3.04$2.72324,108 shs$56.79 million Get the Latest News and Ratings for ADVM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adverum Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$2.93$2.93$3.01$2.75307,558 shs$60.95 million04/17/2025$2.98$2.93-1.68%$3.01$2.75307,558 shs$60.95 million04/16/2025$3.23$2.98-7.74%$3.31$2.89328,983 shs$61.99 million04/15/2025$3.43$3.23-5.83%$3.71$3.11178,069 shs$67.19 million04/14/2025$3.43$3.43$3.59$3.26140,269 shs$71.35 million04/11/2025$3.33$3.43+3.00%$3.48$3.22166,601 shs$71.35 million04/10/2025$3.58$3.33-6.98%$3.71$3.20134,894 shs$69.27 million04/09/2025$3.40$3.58+5.29%$3.70$3.07177,698 shs$74.47 million04/09/2025$3.40$3.58+5.29%$3.70$3.07177,698 shs$74.47 million04/08/2025$3.63$3.40-6.34%$3.80$3.32142,956 shs$70.73 million04/08/2025$3.63$3.40-6.34%$3.80$3.32142,956 shs$70.73 million04/07/2025$3.86$3.63-5.96%$3.89$3.41224,027 shs$75.51 million04/04/2025$3.94$3.86-2.03%$4.01$3.76142,289 shs$80.30 million04/03/2025$4.26$3.94-7.51%$4.12$3.77151,801 shs$81.96 million04/02/2025$3.83$4.26+11.23%$4.40$3.78153,732 shs$88.62 million04/01/2025$4.37$3.83-12.36%$4.48$3.81270,695 shs$79.67 million Related Companies CDTX Stock Price Chart HUMA Stock Price Chart DRUG Stock Price Chart LFCR Stock Price Chart ALMS Stock Price Chart IMMP Stock Price Chart CRVS Stock Price Chart YMAB Stock Price Chart FHTX Stock Price Chart PROK Stock Price Chart Receive ADVM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adverum Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADVM) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adverum Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adverum Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADVM Stock Free ADVM Stock Alerts